Daily Edition · Page 1

THE DAILY INDEX

Technology, AI, software, security, crypto and business

Across today’s newsletters

Today’s Index

OPENAI UNVEILS GPT-4.5 ‘ORION,' ITS LARGEST AI MODEL YET

OpenAI is now rolling out GPT-4.5 to ChatGPT Pro subscribers and developers on paid tiers of the company's API. Other users should get the model sometime next week. GPT-4.5 is so expensive to run that OpenAI is evaluating whether to continue serving the model on its API in the long term. It currently costs $75 for every million input tokens and $150 for every million output tokens. This article looks at how the new model compares to OpenAI's other offerings.

SEC SAYS MEMECOINS AREN'T SECURITIES BUT FRAUD STILL A RISK

The U.S. SEC's Division of Corporation Finance stated memecoins do not qualify as securities under federal law, as they lack profit promises or ties to business ventures, exempting them from registration. However, the SEC warned that projects falsely labeling tokens as memecoins to evade regulations could face legal action, emphasizing fraud risks under other laws. This stance aligns with a more crypto-friendly SEC approach under new leadership, including Chair Paul Atkins and Commissioner Hester Peirce's task force, following recent case withdrawals against major platforms like Coinbase.

ANTI-AGING PILL FOR DOGS CERTIFIED AS 'EFFECTIVE' BY FDA. BUT COULD IT WORK FOR HUMANS, TOO?

Biotech startup Loyal has received a certification from the US Food and Drug Administration (FDA) saying its anti-aging pill for dogs has a reasonable expectation of efficacy. The pill still needs to be certified by the FDA that it is safe for use and can be manufactured at a greater scale before it can be prescribed by veterinarians. Loyal plans to earn conditional approval from the FDA by the end of the year.

TLDR IndexPage 1